| Literature DB >> 21206658 |
Nitin Gupta1, Pamposh Raina, Anant Kumar.
Abstract
Of the various options for patients with end stage renal disease, kidney transplantation is the treatment of choice for a suitable patient. The kidney for transplantation is retrieved from either a cadaver or a live donor. Living donor nephrectomy has been developed as a method to address the shortfall in cadaveric kidneys available for transplantation. Laparoscopic living donor nephrectomy (LLDN), by reducing postoperative pain, shortening convalescence, and improving the cosmetic outcome of the donor nephrectomy, has shown the potential to increase the number of living kidney donations further by removing some of the disincentives inherent to donation itself. The technique of LLDN has undergone evolution at different transplant centers and many modifications have been done to improve donor safety and recipient outcome. Virtually all donors eligible for an open surgical procedure may also undergo the laparoscopic operation. Various earlier contraindications to LDN, such as right donor kidney, multiple vessels, anomalous vasculature and obesity have been overcome with increasing experience. Laparoscopic live donor nephrectomy can be done transperitoneally or retroperitoneally on either side. The approach is most commonly transperitoneal, which allows adequate working space and easy dissection. A review of literature and our experience with regards to standard approach and the modifications is presented including a cost saving model for the developing countries. An assessment has been made, of the impact of LDN on the outcome of donor and the recipient.Entities:
Keywords: donor nephrectomy; transplant; warm ischemia
Year: 2005 PMID: 21206658 PMCID: PMC3004117 DOI: 10.4103/0972-9941.19262
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1Standard ports for left transperitoneal donor
Figure 2Standard ports for left transperitoneal donor
Figure 3Two finger technique for graft retrieval
Figure 4Five-centimeter final incision
Figure 5Site for ports for left retroperitoneal donor
Comparison between Transperitoneal and retroperitoneal LDN
| SGPGIMS Retroperitoneal | Gill et al | Buell et al | Transperitoneal | |
|---|---|---|---|---|
| Patients (n) | 33 | 35 | 28 | 96 |
| Side L:R | 25:8 | 35 | 0:28 | 0:96 |
| Operative time (min) | 192 (150–330) | 160 (120–210) | 190.4 | 235 |
| Blood Loss (ml) | 100 (50–500) | 80 (50–150) | 107.8 (50–400) | 139.2 (20–1200) |
The Donor
| Investigator | No. of Patients | WIT(min) | EBL (ml) | OR time (min) | Open conversion (%) | Hosp.Stay (days) | |
|---|---|---|---|---|---|---|---|
| Ratner | LDN | 70 | — | 266 | 230 | — | 3 |
| ODN | 20 | — | 393 | 183 | — | 5.7 | |
| Rawlins | LDN | 100 | 2.3 | 102 | 231 | 1 | 3.3 |
| ODN | 50 | — | 193 | 209 | — | 4.7 | |
| Simforoosh | LDN | 40 | 6.6 | — | 251 | 2.5 | 2.2 |
| ODN | 40 | 2.09 | — | 135 | — | 2.1 | |
| Jacobs | LDN | 738 | 2.81 | 128 | 202 | 1.6 | 2.6 |
| EL Galley | LDN | 28 | 3 | 200 | 306 | 0 | 2 |
| ODN | 55 | 2 | 320 | 163 | — | 3 | |
| SGPGIMS | LDN | 300 | 4.5 | 85 | 180 | 12 | 3.14 |
| ODN | 1000 | 2 | 220 | 110 | — | 5.7 |
WIT = Warm Ischemia Time
EBL= Estimated Blood Loss
OR time = Operation Room Time
Donor outcome–quality of life parameters
| Ratner | Odland | lowers | ||||
|---|---|---|---|---|---|---|
| Parameters | LDN | ODN | LDN | ODN | LDN | ODN |
| n | 25 | 37 | 26 | 30 | 70 | 65 |
| PO intake (d) | — | — | — | — | 1.7 | 3.2 |
| LOS (d) | 2.9 | 5.5 | 1.0 | 2.5 | 1.2 | 2.5 |
| Analgesic usage (mg) | 4.2 | 11.8 | 1.0 | 2.5 | 1.2 | 2.5 |
| Driving (wks) | 1.9 | 3.2 | — | — | 1.6 | 4.5 |
| Caring for home (wks) | 1.8 | 4.5 | — | — | 1.3 | 3.8 |
| Full activity (wks) | — | — | 1.4 | 3.6 | — | — |
| Return to work (wks) | 4.4 | 6.3 | 2.7 | 5.3 | 2.3 | 7.4 |
| Exercising (wks) | 3.6 | 9.4 | — | — | — | — |
LOS = Length of Hospital Stay
Recipient outcome
| Variables | SGPGIMSSoulsby | Simforoosh | |||
|---|---|---|---|---|---|
| ODN n=1000 | LDN n=300 | LDN n=54 | ODN n=40 | LDN n=40 | |
| S. Creat. (preop.) | 5.1 | 5.34 | — | — | — |
| S. Creat. (day 1) | 2.36 | 2.56 | — | — | — |
| S. Creat. (day 3) | 1.71 | 1.63 | 1.68 | 1.46 | 1.91 |
| S. Creat. (day 7) | 1.69 | 1.72 | 1.67 | — | 2.0 |
| S. Creat. (1M) | 1.25 | 1.28 | — | — | 1.7 |
| S. Creat. (3M) | 1.35 | 1.42 | 1.19 | 1.37 | 1.32 |
| S. Creat. (6 M) | 1.46 | 1.41 | 1.22 | 1.43 | 1.23 |
| S. Creat. (1y) | 1.51 | 1.52 | 1.26 | — | — |
| Return to normal S. | |||||
| Creat. (day2) % | 56% | 51% | — | — | — |
| Return to normal S. | |||||
| Creat. (day 5) % | 78% | 76% | — | — | — |
| Rejection (3 M) % | 27.5% | 25.4% | 22 | — | — |
| ATN (3 M) % | 12.9% | 13.5% | — | — | — |